NRF2 ACTIVATORS FOR THE PREVENTION AND/OR TREATMENT OF AXONAL DEGENERATION
IDIBELL
Filing date: 19 Apr, 2018
15/957,601 N/Ref.: 20171361
ICREA selects researchers based solely on their scientific achievements. However, excellent science often leads to the invention of new and amazing technologies and solutions. When that happens, ICREA fully supports the exploitation of these opportunities.
Our ICREA research professors are working in different Universities and Research Centres. On account of this, ownership of any intellectual or industrial property is always shared between ICREA and the host institution. To make negotiations as fast and conclusive as possible, host institutions are entitled to explore and engage in technology transfer activities on behalf of ICREA when opportunities arise. ICREA supports the exploitation efforts and offers advice throughout the process.
Please have a look at our current technologies and contact ICREA to learn more about them.
IDIBELL
Filing date: 19 Apr, 2018
15/957,601 N/Ref.: 20171361
Mosaic Biomedicals, S.L.U., et al
Filing date: 12 Apr, 2018
18382248.5-1111
CSIC-IMB
Filing date: 12 Mar, 2018
EP18382158
Institut Català de Nanociència i Nanotecnologia
Filing date: 15 Feb, 2018
WO2019158694
Institute for Bioengineering of Catalonia
Filing date: 27 Dec, 2017
P3891EP00
ICFO and ICREA
Filing date: 30 Nov, 2017
Licenced date: 21 Sep, 2018
PCT114973
ICFO
Filing date: 17 Nov, 2017
Licenced date: 17 Nov, 2017
WO2019099826 (A1)
Filing date: 15 Nov, 2017
EP17382772
ICFO and ICREA
Filing date: 6 Nov, 2017
Licenced date: 24 Nov, 2017
PCT/ES2017/070734
Osmotex AG
Filing date: 8 Sep, 2017
Licenced date: 16 Jun, 2020
WO/2018/046659